Srivastava, D., Ieda, M., Fu, J., & Qian, L
Helps support consistent handling during controlled research workflows
Qualified scientific researchers
The vial of BPC-157 contained lead, the vial of TB-500 contained endotoxins, and the vial of CJC-1295 contained less than forty-two per cent of the advertised dose
Repeated-dose toxicity studies, particularly in dogs, have shown that BPC 157 is well tolerated, with no significant adverse effects observed
Commonly reported side effects of BPC 157 are minimal but may include: Mild nausea or dizziness Redness or soreness at the injection site Headaches in some cases These symptoms are usually temporary and resolve quickly